Phase III Randomized Trial of Adjuvant Chemotherapy With S-1 vs S-1/Oxaliplatin +/- Radiotherapy for Completely Resected Gastric Adenocarcinoma : The ARTIST II Trial (ARTIST-II)
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- Acronyms ARTIST-II
- 15 Feb 2017 Planned End Date changed from 1 Jan 2016 to 1 Dec 2020.
- 30 Apr 2015 Planned number of patients changed from 1000 to 900 as reported by ClinicalTrials.gov record.
- 23 Jan 2013 New trial record